Additionally, we found that this compound could arrest cell cycle at G0/G1 phase and induce apoptosis by regulating p38 and JNK/MAPK pathways in Hep3B and HepG2 cells, providing a new, safe, and effective agent for the treatment of HCC. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.